Entrez Id: |
80339 |
Gene Symbol: |
PNPLA3 |
PNPLA3
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium.
|
31219225 |
2019 |
Entrez Id: |
25841 |
Gene Symbol: |
ABTB2 |
ABTB2
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
5520 |
Gene Symbol: |
PPP2R2A |
PPP2R2A
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
27303 |
Gene Symbol: |
RBMS3 |
RBMS3
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
9933 |
Gene Symbol: |
PUM3 |
PUM3
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
84871 |
Gene Symbol: |
AGBL4 |
AGBL4
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
PDCD4-AS1
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
24 |
Gene Symbol: |
ABCA4 |
ABCA4
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
283450 |
Gene Symbol: |
HECTD4 |
HECTD4
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
The Korea Biobank Array: Design and Identification of Coding Variants Associated with Blood Biochemical Traits.
|
30718733 |
2019 |
Entrez Id: |
114879 |
Gene Symbol: |
OSBPL5 |
OSBPL5
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
|
31311600 |
2019 |
Entrez Id: |
7407 |
Gene Symbol: |
VARS1 |
VARS1
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
2805 |
Gene Symbol: |
GOT1 |
GOT1
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
The Korea Biobank Array: Design and Identification of Coding Variants Associated with Blood Biochemical Traits.
|
30718733 |
2019 |
Entrez Id: |
27115 |
Gene Symbol: |
PDE7B |
PDE7B
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium.
|
31219225 |
2019 |
Entrez Id: |
11174 |
Gene Symbol: |
ADAMTS6 |
ADAMTS6
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
TMEM132D
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
8036 |
Gene Symbol: |
SHOC2 |
SHOC2
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
80339 |
Gene Symbol: |
PNPLA3 |
PNPLA3
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
54733 |
Gene Symbol: |
SLC35F2 |
SLC35F2
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
10906 |
Gene Symbol: |
TRAFD1 |
TRAFD1
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
The Korea Biobank Array: Design and Identification of Coding Variants Associated with Blood Biochemical Traits.
|
30718733 |
2019 |
Entrez Id: |
5789 |
Gene Symbol: |
PTPRD |
PTPRD
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
|
31311600 |
2019 |
Entrez Id: |
121601 |
Gene Symbol: |
ANO4 |
ANO4
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
80333 |
Gene Symbol: |
KCNIP4 |
KCNIP4
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
10842 |
Gene Symbol: |
PPP1R17 |
PPP1R17
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
Biomarker and Genomic Risk Factors for Liver Function Test Abnormality in Hazardous Drinkers.
|
30589442 |
2019 |
Entrez Id: |
217 |
Gene Symbol: |
ALDH2 |
ALDH2
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
The Korea Biobank Array: Design and Identification of Coding Variants Associated with Blood Biochemical Traits.
|
30718733 |
2019 |
Entrez Id: |
6671 |
Gene Symbol: |
SP4 |
SP4
|
Aspartate aminotransferase measurement
|
0.100 |
GeneticVariation |
GWASCAT |
GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
|
31311600 |
2019 |